Table 3 Hazard ratio of 30-day mortality associated with muscle mass index.

From: The effects of muscle mass and quality on mortality of patients with acute kidney injury requiring continuous renal replacement therapy

Variable

Model 1

Model 2

Model 3

SMA/BMI

 Q1

1 [Reference]

1 [Reference]

1 [Reference]

 Q2

1.01 (0.86,1.19)

0.85 (0.60,1.20)

0.77 (0.53,1.11)

 Q3

0.83 (0.71,0.99)

0.75 (0.51,1.09)

0.66 (0.44,0.99)

 Q4

0.73 (0.61,0.86)

0.66 (0.44,0.98)

0.58 (0.38,0.88)

 P for trend

0.01

0.03

0.01

 Linear

0.84 (0.78,0.92)

0.84 (0.69,1.01)

0.79 (0.65,0.97)

NAMA /BMI

 Q1

1 [Reference]

1 [Reference]

1 [Reference]

 Q2

0.92 (0.78,1.09)

0.69 (0.49,0.98)

0.70 (0.49,1.01)

 Q3

0.82 (0.69,0.97)

0.63 (0.44,0.89)

0.67 (0.47,0.97)

 Q4

0.74 (0.62,0.88)

0.89 (0.61,1.31)

1.05 (0.71,1.57)

 P for trend

 < 0.001

0.53

0.8

 Linear

0.85 (0.78,0.93)

0.99 (0.82,1.19)

1.07 (0.88,1.31)

LAMA /BMI

 Q1

1 [Reference]

1 [Reference]

1 [Reference]

 Q2

0.95 (0.80,1.12)

0.98 (0.71,1.36)

0.98 (0.70,1.37)

 Q3

1.06 (0.90,1.25)

0.96 (0.70,1.32)

0.93 (0.67,1.28)

 Q4

0.94 (0.79,1.11)

0.81 (0.58,1.11)

0.61 (0.44,0.86)

 P for trend

0.78

0.19

0.01

 Linear

0.97 (0.90,1.04)

0.84 (0.72,0.97)

0.74 (0.64,0.87)

  1. The table illustrates the hazard ratio of 30-day mortality associated with an increase in skeletal muscle mass (SMA), normal attenuation muscle area (NAMA), and low attenuation muscle area (LAMA) adjusted by BMI in various models.